A rare adverse reaction to ethambutol: Drug-induced haemolytic anaemia

International Journal of Tuberculosis and Lung Disease

Volumn 20, Issue 5, 2016, Pages 704-705

  Nicolini, A ^a   Perazzo, A ^a   Gatto, P ^a   Piroddi, I M G ^a   Barlascini, C ^b   Karamichali, S ^c   Strada, P ^d  

^a Hospital of Sestri Levante   (Italy)

^b GENERAL HOSPITAL   (Italy)

^c Department of Allergy and Respiratory Diseases ^*  (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute renal failure; Drug induced anaemia; Tuberculosis

Indexed keywords

BILIRUBIN; DOPAMINE; ETHAMBUTOL; HAPTOGLOBIN; HEMOGLOBIN; ISONIAZID; METHYLPREDNISOLONE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADVERSE OUTCOME; AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTERIUM EXAMINATION; BILIRUBIN BLOOD LEVEL; BRONCHOSCOPY; CASE REPORT; CHILL; COOMBS TEST; DRUG SAFETY; FEVER; GENERAL CONDITION DETERIORATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; JAUNDICE; LABORATORY TEST; LUNG LAVAGE; LUNG TUBERCULOSIS; MALE; MEDICAL HISTORY; POLYMERASE CHAIN REACTION; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREMOR; ANEMIA, HEMOLYTIC, AUTOIMMUNE; CHEMICALLY INDUCED; FATALITY; RISK FACTOR; SILICOTUBERCULOSIS;

AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTITUBERCULAR AGENTS; ETHAMBUTOL; FATAL OUTCOME; HUMANS; MALE; RISK FACTORS; SILICOTUBERCULOSIS;

EID: 84963971152     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0742     Document Type: Article

References (9)

1. Seddon J A, Hesseling A C, Godfrey P, Schaaf H S. High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study. Thorax 2014; 69: 458-464.
2. Ezer N, Benedetti A, Darvish-Zargar M, Menzies D. Incidence of ethambutol-related visual impairment during treatment of active tuberculosis. Int J Tuberc Lung Dis 2013; 17: 447-455.
3. Sivakumaran P, Harrison A C, Marschner J, Martin P. Ocular toxicity from ethambutol: a review of four cases and recommended precautions. NZ Med J 1998; 111: 428-430.
4. Ahrens N, Genth R, Salama A. Belated diagnosis in three patients with rifampicin-induced immune haemolytic anaemia. Br J Haematol 2002; 117: 441-443.
5. Freedman J, Lim F C. An immunohemathologic complication of isoniazid. Vox San 1978; 35: 126-128.
6. Covic A, Golea O, Segall L, et al. A clinical description of rifampicin-induced acute renal failure in 170 consecutive cases. J Indian Med Assoc 2004; 102: 22-25.
7. de Sa' Goncalves H, de Andrade Pontes M A, Buhrer-Sekula S, et al. Brazilian clinical trial of uniform multidrug therapy for leprosy patients-the correlations between clinical disease types and adverse effects. Mem Inst Oswaldo Cruz 2012; 107 (Suppl 1): S74-S78.
8. Habibi B, Bretagne Y. Blood group antigens may be the receptors for immunoallergic drug complexes reacting with erythrocytes. C R Seances Acad Sci III 1983; 296: 693-696. [French]
9. Barcellini W. Current treatment strategies in autoimmune hemolytic disorders. Expert Rev Hematol 2015; 31: 1-11.